Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
1,058.94
-3.12 (-0.29%)
At close: Apr 23, 2025
92.55%
Market Cap 101.85B
Revenue (ttm) 68.18B
Net Income (ttm) 5.23B
Shares Out 97.90M
EPS (ttm) 53.46
PE Ratio 19.46
Forward PE n/a
Dividend 10.00 (0.94%)
Ex-Dividend Date Apr 14, 2025
Volume 2,455
Average Volume 15,672
Open 1,055.00
Previous Close 1,062.06
Day's Range 1,055.00 - 1,069.00
52-Week Range 540.00 - 1,310.00
Beta 0.47
RSI 40.60
Earnings Date Apr 25, 2025

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; AND import and marketing of nutritional products. It imports and markets diagnostic equipment, molecu... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1888
Employees 1,406
Stock Exchange Pakistan Stock Exchange
Ticker Symbol ABOT
Full Company Profile

Financial Performance

In 2024, PSX:ABOT's revenue was 68.18 billion, an increase of 22.90% compared to the previous year's 55.48 billion. Earnings were 5.23 billion, an increase of 1899.50%.

Financial Statements

News

There is no news available yet.